STEFANIE SWINGLE: Open Payments
NPI 1467769414 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 7 payments from 7 companies in 2025. Trend: 2023 $63 · 2024 $74 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $122 |
| BETA BIONICS, INC. | 1 | $120 |
| Dexcom, Inc. | 1 | $73 |
| Biogen, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: RECORLEV, Kerendia, iLet Bionic Pancreas, Dexcom G6 Transmitter, SKYCLARYS, MOUNJARO, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
